Top compounds associated with response to ABL2


Feature Type Standardized
Nominal ANOVA
mRNA bid1870 gCSI pan-cancer AAC 0.28 9e-07
mRNA austocystin d CTRPv2 pan-cancer AAC -0.19 3e-06
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.17 4e-06
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.18 4e-06
mRNA simvastatin CTRPv2 pan-cancer AAC 0.19 7e-06
mRNA linifanib CTRPv2 pan-cancer AAC -0.18 8e-06
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.17 8e-06
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.15 1e-05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.15 3e-05
Download CSV